Redbiotec Pivots Toward HSV-2 Therapies And Therapeutic Bacteria

Redbiotec has reached a new inflection point as it progresses two key programs in herpes and cancer. The company’s CEO and CSO explain how it hopes to use bacteria as a delivery system for genes or proteins to treat cancer.

Link to the article